| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 45.79B | 45.76B | 44.54B | 37.73B | 32.44B | 28.16B |
| Gross Profit | 18.24B | 18.20B | 18.33B | 12.92B | 11.03B | 9.70B |
| EBITDA | 8.04B | 8.15B | 7.96B | 6.27B | 3.97B | 3.39B |
| Net Income | 4.39B | 4.47B | 4.46B | 4.26B | 2.40B | 2.09B |
Balance Sheet | ||||||
| Total Assets | 52.67B | 54.15B | 49.10B | 45.25B | 38.45B | 32.42B |
| Cash, Cash Equivalents and Short-Term Investments | 8.35B | 8.88B | 8.39B | 8.93B | 8.78B | 7.13B |
| Total Debt | 3.38B | 2.76B | 2.72B | 2.73B | 2.08B | 1.76B |
| Total Liabilities | 15.19B | 16.04B | 15.58B | 16.38B | 13.20B | 9.90B |
| Stockholders Equity | 37.24B | 37.89B | 33.28B | 28.71B | 25.18B | 22.46B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.70B | 1.48B | 620.28M | 2.08B | 1.49B |
| Operating Cash Flow | 0.00 | 3.46B | 2.56B | 1.91B | 2.71B | 2.09B |
| Investing Cash Flow | 0.00 | -784.01M | -2.49B | -1.52B | -429.19M | -920.11M |
| Financing Cash Flow | 0.00 | -1.88B | -1.85B | -419.04M | -579.34M | 149.08M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥59.91B | 10.64 | ― | 2.79% | 2.85% | 3.17% | |
75 Outperform | ¥65.86B | 13.24 | ― | 3.95% | -1.67% | -4.39% | |
72 Outperform | ¥178.75B | 14.12 | 10.28% | 2.77% | 2.74% | 7.86% | |
70 Outperform | ¥166.55B | 7.70 | 8.17% | 2.04% | 1.48% | 58.59% | |
70 Outperform | ¥88.33B | 4.09 | ― | 3.09% | 6.35% | -34.20% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥12.72B | 10.99 | ― | 6.70% | 7.96% | 43.37% |